BULLISHWHALES
BullishWhales · Congress · Trade Detail
XBISPDR Series Trust SPDR S&P Biotech ETF (XBI)
RepublicanHouse

David P. Joyce bought SPDR Series Trust SPDR S&P Biotech ETF (XBI) (XBI)

David P. Joyce (R-OH), a U.S. Representative, has disclosed 2 trades in SPDR Series Trust SPDR S&P Biotech ETF (XBI) (XBI) since 2017, 1 purchase and 1 sale, worth an estimated $41K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: David P. Joyce bought $1,001 - $15,000 of SPDR Series Trust SPDR S&P Biotech ETF (XBI) (XBI) on February 17, 2017. Since that trade, XBI is up +131.90% against the S&P 500 up +271.96%, an outperformance of -140.06%.

Across these filings, David P. Joyce has been a balanced trader of XBI (a buy-to-sell ratio of 1.00). The most recent disclosed XBI transaction shown was dated June 30, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

XBI trades
2
Disclosed Vol
$41K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2017–2023

David P. Joyce's XBI trades vs the price

XBI is up +131.90% since David P. Joyce bought on February 17, 2017, versus +271.96% for the S&P 500.

Performance since this trade

Price change since trade
+131.90%
S&P 500 change since trade
+271.96%
Outperformance vs S&P 500
-140.06%

All David P. Joyce XBI trades

TradedTypeSizeReturnEst. profit
June 30, 2023SELL$82.76+92.16%
February 17, 2017BUY$68.58+131.90%+$11K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

David P. Joyce & XBI trading FAQ

Is it legal for David P. Joyce to trade SPDR Series Trust SPDR S&P Biotech ETF (XBI) (XBI) stock?

Yes. Members of Congress are allowed to trade individual stocks, including SPDR Series Trust SPDR S&P Biotech ETF (XBI) (XBI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did David P. Joyce buy XBI?

David P. Joyce disclosed a purchase of $1,001 - $15,000 of SPDR Series Trust SPDR S&P Biotech ETF (XBI) (XBI) on February 17, 2017, according to public STOCK Act filings.

How has XBI performed since David P. Joyce's trade?

Since David P. Joyce bought XBI on February 17, 2017, the stock is up +131.90%, versus +271.96% for the S&P 500 over the same period, an outperformance of -140.06%.

How many times has David P. Joyce traded XBI?

David P. Joyce has disclosed 2 XBI trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional XBI trades?

BullishWhales tracks every disclosed congressional trade in SPDR Series Trust SPDR S&P Biotech ETF (XBI) (XBI) on the SPDR Series Trust SPDR S&P Biotech ETF (XBI) congressional trading page, which aggregates filings across all members of Congress.

David P. Joyce's XBI tradesAll congressional filings for SPDR Series Trust SPDR S&P Biotech ETF (XBI)David P. Joyce's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30